Abstract Details

Title Saliva Soluble HLA Class II in MS: A Potential Marker of Response to Treatment with Interferon-Beta1a (Rebif)

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 141

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alireza Minagar, MD	No disclosure on file
Irena Adamashvili, PhD	No disclosure on file
Roger E. Kelley, Jr., MD, F�鶹��ýӳ�� (LSU Health Sciences Center)	Dr. Kelley has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file